Hisanori Shinohara Selected Research

Hisanori Shinohara Research Topics

Disease

5	AIDS-Related Complex (ARC) 12/2017 - 01/2001
3	Carcinogenesis 02/2015 - 12/2011
3	Myocardial Infarction 01/2004 - 11/2002
2	Atherosclerosis 12/2020 - 01/2004
2	Hypertension (High Blood Pressure) 12/2020 - 01/2004
2	Hypercholesterolemia 03/2008 - 08/2004
2	Ventricular Remodeling 04/2004 - 11/2002
2	Heart Failure 04/2004 - 12/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2004 - 10/2002
2	Stable Angina 01/2004 - 08/2003
1	Sarcopenia 12/2020
1	Type 2 Diabetes Mellitus (MODY) 12/2020
1	Dyslipidemias (Dyslipidemia) 12/2020
1	Photosensitivity Disorders (Photodermatitis) 12/2017
1	Neoplasms (Cancer) 07/2017
1	Inflammation (Inflammations) 02/2015
1	Malignant Mesothelioma 09/2013
1	Mesothelioma 12/2011
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 11/2006
1	Atrioventricular Nodal Reentry Tachycardia (AV Nodal Reentrant Tachycardia) 06/2004
1	Persistent Left Superior Vena Cava 06/2004
1	Diabetes Mellitus 01/2004
1	Coronary Disease (Coronary Heart Disease) 01/2004
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2004
1	Unstable Angina 08/2003
1	Acute Coronary Syndrome 08/2003
1	Pathologic Constriction (Stenosis) 05/2003
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2002

Drug/Important Bio-Agent (IBA)

2	FullerenesIBA 12/2017 - 12/2002
2	SootIBA 03/2014 - 12/2002
2	Carbon Nanotubes (Carbon Nanotube)IBA 09/2013 - 12/2011
2	AsbestosIBA 09/2013 - 12/2011
2	Atorvastatin (Lipitor)FDA Link 03/2008 - 08/2004
2	LipidsIBA 08/2004 - 01/2004
2	Angiotensin Receptor AntagonistsIBA 04/2004 - 12/2002
2	Cell Adhesion MoleculesIBA 01/2004 - 08/2003
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	Polytetrafluoroethylene (Teflon)FDA Link 12/2017
1	Singlet OxygenIBA 12/2017
1	SolventsIBA 11/2017
1	Contrast MediaIBA 07/2017
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 03/2014
1	CarcinogensIBA 09/2013
1	MetalsIBA 11/2006
1	TerbiumIBA 11/2006
1	LDL Lipoproteins (beta Lipoproteins)IBA 08/2004
1	Plasminogen InactivatorsIBA 08/2004
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2004
1	cadherin 5IBA 01/2004
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2003
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 08/2003
1	P-SelectinIBA 08/2003
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2003
1	DysprosiumIBA 12/2002
1	3-Iodobenzylguanidine (Iobenguane)IBA 12/2002
1	Angiotensin IIIBA 12/2002
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2002
1	Plasminogen Activator Inhibitor 1IBA 10/2002
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2002
1	C-Reactive ProteinIBA 10/2002
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2002
1	PowdersIBA 01/2001
1	GraphiteIBA 01/2001

Therapy/Procedure

2	Therapeutics 08/2004 - 04/2004
1	Glycemic Control 12/2020
1	Intraperitoneal Injections 02/2015
1	Catheter Ablation 06/2004
1	Synchrotrons 01/2001